Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $24,600 | 9 | 54.8% |
| Travel and Lodging | $13,747 | 26 | 30.6% |
| Unspecified | $2,801 | 5 | 6.2% |
| Food and Beverage | $2,574 | 70 | 5.7% |
| Gift | $950.40 | 16 | 2.1% |
| Education | $200.42 | 7 | 0.4% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| MannKind Corporation | $36,550 | 63 | $0 (2023) |
| Medtronic MiniMed, Inc. | $4,029 | 17 | $0 (2020) |
| Medtronic, Inc. | $3,187 | 8 | $0 (2023) |
| Novo Nordisk Inc | $388.91 | 11 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $294.60 | 5 | $0 (2023) |
| Dexcom, Inc. | $167.16 | 20 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $92.48 | 4 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $85.77 | 1 | $0 (2023) |
| Amgen Inc. | $42.56 | 2 | $0 (2017) |
| Cook Medical LLC | $17.78 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $199.43 | 21 | Dexcom, Inc. ($167.16) |
| 2023 | $1,974 | 11 | Medtronic, Inc. ($1,612) |
| 2022 | $17,419 | 23 | Mannkind Corporation ($15,686) |
| 2021 | $21,154 | 57 | MannKind Corporation ($20,799) |
| 2020 | $3,862 | 17 | Medtronic MiniMed, Inc. ($3,807) |
| 2018 | $222.28 | 2 | Medtronic MiniMed, Inc. ($222.28) |
| 2017 | $42.56 | 2 | Amgen Inc. ($42.56) |
All Payment Transactions
133 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $10.59 | General |
| Category: Endocrinology | ||||||
| 12/17/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $8.73 | General |
| Category: Endocrinology | ||||||
| 11/25/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: Endocrinology | ||||||
| 11/14/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $7.73 | General |
| Category: Endocrinology | ||||||
| 10/31/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Endocrinology | ||||||
| 09/24/2024 | Novo Nordisk Inc | Ozempic (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 09/20/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $5.98 | General |
| Category: Endocrinology | ||||||
| 09/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $5.88 | General |
| Category: Endocrinology | ||||||
| 09/04/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $5.77 | General |
| Category: Endocrinology | ||||||
| 07/08/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $4.54 | General |
| Category: Endocrinology | ||||||
| 06/17/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Endocrinology | ||||||
| 05/31/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $9.09 | General |
| Category: Endocrinology | ||||||
| 05/07/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: Endocrinology | ||||||
| 04/09/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $6.73 | General |
| Category: Endocrinology | ||||||
| 04/04/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $2.54 | General |
| Category: Endocrinology | ||||||
| 04/01/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $2.63 | General |
| Category: Endocrinology | ||||||
| 03/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: Endocrinology | ||||||
| 02/23/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $5.98 | General |
| Category: Endocrinology | ||||||
| 02/12/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $10.27 | General |
| Category: Endocrinology | ||||||
| 01/24/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $7.66 | General |
| Category: Endocrinology | ||||||
| 01/08/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $7.91 | General |
| Category: Endocrinology | ||||||
| 09/20/2023 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $152.08 | General |
| Category: Durable Pump | ||||||
| 08/29/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Spinal Cord Stimulator | ||||||
| 06/25/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $117.82 | General |
| 06/25/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $32.00 | General |
| Category: Cardio-renal | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| CEP304 HCL Outcomes Study | Medtronic, Inc. | $1,400 | 2 |
| CIP321 AHCL Pivotal Study | Medtronic, Inc. | $875.50 | 1 |
| CIP337 SUCCEED | Medtronic, Inc. | $263.00 | 1 |
| CIP344 780G BLE2.0 2-6RCT | Medtronic, Inc. | $262.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 134 | 314 | $88,605 | $24,802 |
| 2022 | 2 | 93 | 256 | $73,370 | $20,215 |
| 2021 | 5 | 170 | 387 | $114,085 | $35,235 |
| 2020 | 7 | 180 | 323 | $88,085 | $27,461 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 56 | 148 | $47,360 | $13,293 | 28.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 25 | 77 | $16,555 | $4,762 | 28.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 28 | $11,900 | $3,863 | 32.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 18 | $7,200 | $1,736 | 24.1% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 17 | 43 | $5,590 | $1,148 | 20.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 76 | 211 | $67,520 | $18,947 | 28.1% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 17 | 45 | $5,850 | $1,268 | 21.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 88 | 236 | $75,520 | $24,379 | 32.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 28 | 35 | $14,875 | $4,914 | 33.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 16 | 21 | $8,365 | $2,222 | 26.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 19 | 35 | $7,525 | $2,004 | 26.6% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 19 | 60 | $7,800 | $1,716 | 22.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 64 | 153 | $48,960 | $13,326 | 27.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 39 | 60 | $9,900 | $5,496 | 55.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 23 | 23 | $11,155 | $3,098 | 27.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 13 | 17 | $7,225 | $1,998 | 27.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 14 | 25 | $5,375 | $1,526 | 28.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 13 | 20 | $2,220 | $1,283 | 57.8% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2020 | 14 | 25 | $3,250 | $734.71 | 22.6% |
About Dr. Scott Lee, M.D
Dr. Scott Lee, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Loma Linda, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902902042.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Lee, M.D has received a total of $44,873 in payments from pharmaceutical and medical device companies, with $199.43 received in 2024. These payments were reported across 133 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($24,600).
As a Medicare-enrolled provider, Lee has provided services to 577 Medicare beneficiaries, totaling 1,280 services with total Medicare billing of $107,712. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Loma Linda, CA
- Active Since 09/16/2006
- Last Updated 07/01/2008
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1902902042
Products in Payments
- AFREZZA (Drug) $36,550
- MINIMED 670G (Device) $2,451
- Minimed 670G System (Device) $986.53
- Guardian Sensor 3 (Device) $681.58
- Kerendia (Drug) $294.60
- Minimed 530G (Device) $222.28
- MINIMED 780G (Device) $211.18
- Dexcom G6 Transmitter (Medical Supply) $167.16
- Ozempic (Drug) $54.66
- TZIELD (Biological) $45.48
- Repatha (Biological) $42.56
- SOLIQUA 100/33 (Biological) $32.57
- Saxenda (Drug) $32.27
- Hemospray (Device) $17.78
- Senza (Device) $17.00
- TOUJEO (Biological) $14.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Loma Linda
Takahiro Otsuka, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $11,449
Dr. Matheni Sathananthan, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $870.86
Tania Arous, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $637.76
Dr. Eujean Park
Endocrinology, Diabetes & Metabolism — Payments: $164.91
Hye Jeong Han
Endocrinology, Diabetes & Metabolism — Payments: $94.50
Olha Fomenko, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $38.10